ID: ALA5093237

Max Phase: Preclinical

Molecular Formula: C19H21FN4S

Molecular Weight: 356.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cn(-c2ccc(-c3csc(NC4CCCCC4)n3)cc2F)cn1

Standard InChI:  InChI=1S/C19H21FN4S/c1-13-10-24(12-21-13)18-8-7-14(9-16(18)20)17-11-25-19(23-17)22-15-5-3-2-4-6-15/h7-12,15H,2-6H2,1H3,(H,22,23)

Standard InChI Key:  AEXCFKOCEGNDES-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-secretase 4915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.47Molecular Weight (Monoisotopic): 356.1471AlogP: 5.19#Rotatable Bonds: 4
Polar Surface Area: 42.74Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.85CX LogP: 4.66CX LogD: 4.65
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.70Np Likeness Score: -1.95

References

1. Bhattarai S, Liu L, Wolfe MS..  (2021)  Discovery of aryl aminothiazole γ-secretase modulators with novel effects on amyloid β-peptide production.,  54  [PMID:34767913] [10.1016/j.bmcl.2021.128446]

Source